Reglagene

Cancer is the number two killer of Americans. It will soon pass heart disease as the leading cause of death worldwide. Conventional approaches to creating new cancer therapies often fail to deliver. At Reglagene, we give hope to cancer patients through the creation of new medicines that attack cancer’s weaknesses in ways that were once out of reach. We earn revenue by licensing our intellectual property to pharmaceutical partners, a $30B market. We are the ONLY company that harnesses Quadruplex Master Switch Technology to discover new medicines.